The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts

INTRODUCTION: Tumor Treating Fields (TTFields, 200 kHz) therapy is a noninvasive, locoregional cancer treatment approved for use in newly diagnosed glioblastoma (GBM), recurrent GBM, and malignant pleural mesothelioma. GBM patients with hydrocephalus may require implantation of a ventriculoperitonea...

Descripción completa

Detalles Bibliográficos
Autores principales: Oberheim-Bush, Nancy Ann, Shi, Wenyin, McDermott, Michael W., Grote, Alexander, Stindl, Julia, Lustgarten, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256561/
https://www.ncbi.nlm.nih.gov/pubmed/35639236
http://dx.doi.org/10.1007/s11060-022-04033-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256561/
https://www.ncbi.nlm.nih.gov/pubmed/35639236
http://dx.doi.org/10.1007/s11060-022-04033-4

Ejemplares similares